Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Allison Agwu, MD, MSc (she/her/hers)

Professor
Johns Hopkins University
Baltimore, MD, United States

Dr. Allison Agwu, M.D., ScM is Professor of Adult and Pediatric Infectious Diseases at Johns Hopkins University School of Medicine in Baltimore, Maryland. Dr. Agwu received her Bachelors in Science from University of Maryland, medical degree from University of Maryland School of Medicine, and Masters of Science from Johns Hopkins Bloomberg School of Public Health. She completed her combined internal medicine/pediatric residency at Case Western Reserve University followed by a combined adult/pediatric infectious disease fellowship at Johns Hopkins School of Medicine. Her clinical care and research focuses on deciphering health disparities and optimizing care and treatment strategies and outcomes particularly for young people at-risk for and/or living with HIV. Dr. Agwu oversees a clinical research program that aims to coordinate care, treatment, and research for often marginalized populations through a multidisciplinary and socially responsible lens. She cares for patients across the age spectrum, both in the pediatric and adult Ryan-White funded HIV clinics at Johns Hopkins, as the founder and medical director of the Accessing Care Early (ACE) Clinic and the Program Director of the Pediatric/Adolescent HIV/AIDS Program. Dr. Agwu’s independent research studies uses multimodal approaches, including clinic and field-based approaches and clinical trials. She is also involved with large national and international research groups. She is an active member of the U.S. Department of Health and Human Services’ Adolescent and Adult Antiretroviral Treatment Guidelines and is the Chair of the Board of Directors for the HIV Medicine Association where she tirelessly advocates for youth of all ages.

Disclosure(s): AbbVie, Angelini, Contrafect, Cubist, Genentech, Gilead Sciences, Jansen, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare: Advisor/Consultant (Terminated, December 20, 2023); Gilead Biosciences: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Merck and Company, Inc.: Advisor/Consultant (Terminated, December 31, 2022), Grant/Research Support (Terminated, December 31, 2022)

Presentation(s):